Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
A federal lawsuit claims Meta’s Ray-Ban AI glasses expose user footage to human reviewers overseas, challenging the c...
VCR is down about 9% year-to-date, but nearly 40% of its holdings sit in Amazon and Tesla, reshaping the fund’s risk ...
AMD delivered a strong Q1 FY2026, prompting a broad uprising in analyst targets. Nine firms boosted price targets as ...
PayPal reports a solid quarter but the stock falls as the company commits to an AI-driven reorganization. The legacy ...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
A fintech startup faced backlash after an autonomous AI claimed a non-existent policy, underscoring how deployment ch...
Bitcoin tops $80,000 again as Canaccord Genuity raises MicroStrategy’s price target to $224, highlighting a move towa...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
Tapestry reports a record quarter as Coach powerfully taps Gen Z demand with a Goldilocks mix of luxury and accessibi...